← All decks

Dermatology

Dermatitis Herpetiformis and Linear IgA Bullous Dermatosis

Built from Dermatology, 5th Edition

What’s inside

15 sections · 100 slides

  1. 01

    Overview

    • Scope of this topic
    • How this topic is organised
    • Four findings that support a diagnosis of DH

    3 slides

  2. 02

    Dermatitis Herpetiformis: Introduction and History

    A skin disease that is really the visible sign of gluten sensitivity

    • What is dermatitis herpetiformis
    • Course of dermatitis herpetiformis
    • History of dermatitis herpetiformis
    • Dermatitis herpetiformis: historic landmarks
    • Dermatitis herpetiformis: historic landmarks (continued)

    5 slides

  3. 03

    Dermatitis Herpetiformis: Epidemiology

    Who gets DH, and how often

    • Who gets dermatitis herpetiformis
    • How common is dermatitis herpetiformis

    2 slides

  4. 04

    Dermatitis Herpetiformis: Pathogenesis

    How eating gluten ends up causing a blistering rash on the skin

    • Key observations behind the DH mechanism
    • Genetic predisposition in DH
    • Gluten and the gut in DH
    • From gluten to an immune attack: the first steps
    • Proposed pathogenesis of dermatitis herpetiformis and celiac disease
    • How a helper T cell response drives gut and antibody changes
    • How gluten exposure leads to a skin blister
    • Epitope spreading explains DH's timing
    • Circulating antibodies in DH
    • Evidence from animal models
    • Granular IgA deposition: the hallmark of DH
    • Iodide and DH flares

    12 slides

  5. 05

    Dermatitis Herpetiformis: Associated Disorders

    Other autoimmune diseases, and a cancer risk, linked to DH

    • Thyroid disease and lymphoma risk in DH
    • Other autoimmune disorders linked to DH
    • Autoimmune disorders associated with dermatitis herpetiformis

    3 slides

  6. 06

    Dermatitis Herpetiformis: Clinical Features

    What DH looks like on the skin, and where it appears

    • Distribution and lesion types in DH
    • Less common presentations of DH
    • Dermatitis herpetiformis on the elbow and knee
    • Dermatitis herpetiformis on the back, buttocks, and fingertips
    • Multiple pruritic papules with hemorrhagic crusts in DH
    • Hemorrhagic macules on the thumb in DH

    6 slides

  7. 07

    Dermatitis Herpetiformis: Pathology and IgA Deposits

    What a biopsy shows, and why the biopsy site matters

    • Routine histology in DH
    • Dermatitis herpetiformis: histopathologic features
    • Where to biopsy for the IgA stain in DH
    • Direct immunofluorescence in dermatitis herpetiformis
    • How often each IgA deposit pattern is seen in DH

    5 slides

  8. 08

    Dermatitis Herpetiformis: Diagnosis

    Blood tests, the diagnostic work-up, and diseases that mimic DH

    • Laboratory evaluation in DH
    • Approach to the patient with suspected dermatitis herpetiformis
    • Differential diagnosis of DH
    • DH, LABD, and bullous pemphigoid at a glance
    • Characteristics that differentiate DH, LABD, and bullous pemphigoid

    5 slides

  9. 09

    Dermatitis Herpetiformis: Treatment

    Dapsone, its side effects, and the gluten-free diet

    • Dapsone for DH: how it works and how fast
    • Dapsone dosing in DH
    • Facial disease and dapsone side effects overview
    • Dapsone side effects: hemolysis
    • Side effects of dapsone
    • Side effects of dapsone
    • Serious dapsone reactions to watch for
    • Dapsone hypersensitivity syndrome and neuropathy
    • Alternatives to dapsone in DH
    • Monitoring patients on dapsone or sulfapyridine
    • The gluten-free diet in DH
    • Patient support for DH

    12 slides

  10. 10

    Linear IgA Bullous Dermatosis: Introduction and History

    A separate IgA disease, named for a straight line of antibody on the skin

    • What is linear IgA bullous dermatosis
    • The childhood form: chronic bullous disease of childhood
    • Two structural types of LABD
    • Two structural subtypes of LABD
    • History of linear IgA bullous dermatosis
    • Linking the childhood and adult forms at the molecular level

    6 slides

  11. 11

    Linear IgA Bullous Dermatosis: Epidemiology and Pathogenesis

    How common LABD is, and what its antibodies actually target

    • Epidemiology of LABD
    • BP180: the shared target of LABD and bullous pemphigoid
    • BP180 fragments recognised by LABD antibodies
    • Cleavage fragments of BPAG2/BP180 recognised in bullous pemphigoid and LABD
    • The sublamina densa type of LABD
    • Gut and other disease associations of LABD
    • Malignancy and infection triggers of LABD
    • Drug-induced LABD
    • Drugs reported to cause LABD
    • Drug-induced linear IgA bullous dermatosis
    • Drug-induced linear IgA bullous dermatosis from vancomycin

    11 slides

  12. 12

    Linear IgA Bullous Dermatosis: Clinical Features

    A variable rash that can mimic either DH or bullous pemphigoid

    • General clinical picture of LABD
    • Chronic bullous disease of childhood
    • LABD lesions resembling bullous pemphigoid
    • Herpetiform, annular LABD lesions on an inflamed base
    • Striking annular vesiculobullous lesions of LABD on the thigh
    • Circumferential and linear vesicles and bullae in LABD
    • Annular and herpetiform vesiculobullae on the face in childhood LABD
    • Annular vesiculobullous lesions on the hands in LABD
    • Annular and polycyclic plaques of the trunk in LABD
    • Mucosal and drug-induced presentations of LABD

    10 slides

  13. 13

    Linear IgA Bullous Dermatosis: Pathology and Diagnosis

    Biopsy findings, and how LABD is separated from DH and bullous pemphigoid

    • Pathology of LABD
    • Linear IgA bullous dermatosis: histopathologic features
    • Subtyping LABD by electron microscopy
    • Direct immunofluorescence in linear IgA bullous dermatosis
    • Separating LABD from DH and bullous pemphigoid
    • Circulating antibodies and salt-split skin testing in LABD

    6 slides

  14. 14

    Linear IgA Bullous Dermatosis: Treatment

    Dapsone as first-line therapy, steroid-sparing options, and natural course

    • First-line treatment of LABD
    • Dosing in children and other treatment options
    • Natural course of LABD

    3 slides

  15. 15

    Summary

    Bringing DH and LABD back together

    • DH versus LABD: the core contrast
    • Key takeaways
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    11 slides